Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL MANAGEMENT, LLC | 195,515 7.800% | 195,515 (New Position) | Filing History |
| 2025-02-14 4:16 pm Sale | 2024-12-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | Schonfeld Strategic Advisors LLC | 65,746 2.820% | -22,890 (-25.82%) | Filing History |
| 2025-02-07 4:10 pm Sale | 2024-12-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | CVI Investments, Inc. | 122,319 4.900% | -44,348 (-26.61%) | Filing History |
| 2025-01-31 9:31 pm Purchase | 2024-12-18 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 313,445 12.400% | 865 (+0.28%) | Filing History |
| 2024-12-23 11:30 am Purchase | 2024-12-16 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | CVI Investments, Inc. | 166,667 7.200% | 166,667 (New Position) | Filing History |
| 2024-12-20 4:30 pm Purchase | 2024-12-18 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 159,912 6.800% | 15,216 (+10.52%) | Filing History |
| 2024-11-14 5:16 pm Purchase | 2024-09-30 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | Armistice Capital, LLC | 167,898 9.990% | 79,698 (+90.36%) | Filing History |
| 2024-11-14 4:15 pm Purchase | 2024-09-30 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | Schonfeld Strategic Advisors LLC | 88,636 5.300% | 88,636 (New Position) | Filing History |
| 2024-08-23 4:07 pm Purchase | 2024-08-22 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 312,580 16.900% | 312,580 (New Position) | Filing History |
| 2024-08-23 4:06 pm Purchase | 2024-08-22 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 144,696 8.600% | 412 (+0.29%) | Filing History |
| 2024-08-14 4:07 pm Purchase | 2024-08-06 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | Integrated Core Strategies (US) LLC | 78,180 5.200% | 78,180 (New Position) | Filing History |
| 2024-05-31 9:30 pm Sale | 2024-05-29 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | VEDANTA PARTNERS LLC | 312,580 18.500% | -7,641 (-2.39%) | Filing History |
| 2024-02-16 4:32 pm Purchase | 2023-11-20 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 144,284 10.200% | 3,707 (+2.64%) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL PARTNERS LP | 154,931 9.990% | 41,620 (+36.73%) | Filing History |
| 2024-02-14 3:52 pm Purchase | 2023-12-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | Armistice Capital, LLC | 88,200 6.320% | 88,200 (New Position) | Filing History |
| 2023-11-30 4:49 pm Purchase | 2023-11-20 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | VEDANTA PARTNERS LLC | 320,221 19.900% | 16,962 (+5.59%) | Filing History |
| 2023-05-05 4:30 pm Purchase | 2023-04-25 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 140,577 13.500% | 16,634 (+13.42%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL PARTNERS LP | 113,311 9.990% | 45,802 (+67.85%) | Filing History |
| 2022-09-12 4:35 pm Purchase | 2022-09-08 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | VEDANTA PARTNERS LLC | 303,259 19.900% | 138,340 (+83.88%) | Filing History |
| 2022-01-05 12:35 pm Sale | 2021-12-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | SABBY MANAGEMENT LLC | 0 0.000% | -45,236 (Position Closed) | Filing History |